BARBARA RYS: Open Payments
NPI 1639377997 · WARWICK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 43 payments from 14 companies in 2025. Trend: 2023 $1,295 · 2024 $1,425 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $220 |
| PFIZER INC. | 6 | $122 |
| ABBVIE INC. | 3 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Abbott Laboratories | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Lilly USA, LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
Products named: PREVNAR 20, Fabhalta, AIRSUPRA, FARXIGA, UBRELVY, BREZTRI, FREESTYLE LIBRE, MOUNJARO.
Industry payments across NY — which companies pay providers there.
